Eli Lilly’s oral obesity treatment efficacy falls short of expectations, says BMO’s Evan SeigermanAugust 7, 2025
Share Facebook Twitter LinkedIn Pinterest Email Julian Mitchell, Barclays U.S. industrials analyst, joins ‘The Exchange’ to discuss M&A in the industrials sector and which names he believes are next.